Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

W. Zeijlemaker; A. Kelder; Y. J. M. Oussoren-Brockhoff; W. Scholten; A. N. Snel; D. Veldhuizen; J. Cloos; G. J. Ossenkoppele; G. J. Schuurhuis

doi:10.1038/leu.2015.255

Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

W. Zeijlemaker
, A. Kelder
, Y. J. M. Oussoren-Brockhoff
, W. Scholten
, A. N. Snel
, D. Veldhuizen
, J. Cloos
, G. J. Ossenkoppele
, G. J. Schuurhuis

Research output: Contribution to journal › Article › Academic › peer-review

49 Downloads (Pure)

Original language	English
Pages (from-to)	708-715
Journal	Leukemia
Volume	30
Issue number	3
DOIs	https://doi.org/10.1038/leu.2015.255
Publication status	Published - Mar 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/leu.2015.255

Peripheral-blood-minimal-residual-disease-may-replace-bone-marrow-minimal-residual-disease-as-an-immunophenotypic-biomar.pdfFinal published version, 614 KBLicence: Taverne

Cite this

Zeijlemaker, W., Kelder, A., Oussoren-Brockhoff, Y. J. M., Scholten, W., Snel, A. N., Veldhuizen, D., Cloos, J., Ossenkoppele, G. J., & Schuurhuis, G. J. (2016). Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia. Leukemia, 30(3), 708-715. https://doi.org/10.1038/leu.2015.255

@article{f2331b98b1d34654820af23fa7b2db32,

title = "Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia",

author = "W. Zeijlemaker and A. Kelder and Oussoren-Brockhoff, \{Y. J. M.\} and W. Scholten and Snel, \{A. N.\} and D. Veldhuizen and J. Cloos and Ossenkoppele, \{G. J.\} and Schuurhuis, \{G. J.\}",

year = "2016",

month = mar,

doi = "10.1038/leu.2015.255",

language = "English",

volume = "30",

pages = "708--715",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "3",

}

Zeijlemaker, W, Kelder, A, Oussoren-Brockhoff, YJM, Scholten, W, Snel, AN, Veldhuizen, D, Cloos, J , Ossenkoppele, GJ & Schuurhuis, GJ 2016, 'Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia', Leukemia, vol. 30, no. 3, pp. 708-715. https://doi.org/10.1038/leu.2015.255

Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia. / Zeijlemaker, W.; Kelder, A.; Oussoren-Brockhoff, Y. J. M. et al.
In: Leukemia, Vol. 30, No. 3, 03.2016, p. 708-715.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

AU - Zeijlemaker, W.

AU - Kelder, A.

AU - Oussoren-Brockhoff, Y. J. M.

AU - Scholten, W.

AU - Snel, A. N.

AU - Veldhuizen, D.

AU - Cloos, J.

AU - Ossenkoppele, G. J.

AU - Schuurhuis, G. J.

PY - 2016/3

Y1 - 2016/3

U2 - 10.1038/leu.2015.255

DO - 10.1038/leu.2015.255

M3 - Article

C2 - 26373238

SN - 0887-6924

VL - 30

SP - 708

EP - 715

JO - Leukemia

JF - Leukemia

IS - 3

ER -